Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in ghrelin receptor ligands.

Aline Moulin1, Joanne Ryan, Jean Martinez

  • 1Institut des Biomolécules Max Mousseron, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 1441, 34093 Montpellier Cedex, France.

Chemmedchem
|May 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membrane cholesterol modulates engagement of β-arrestin with the ghrelin receptor.

Communications biology·2026
Same author

LEAP2 modulates β-adrenergic triggered cardiac responses and provokes antihypertensive effects.

Life sciences·2026
Same author

Additive effect of leptin and palm-LEAP2(1-14) ameliorates obesity-induced metabolic stress in ob/ob mice.

European journal of pharmacology·2026
Same author

Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Selective Coupling of Aminophosphole-Based Fluorophores to Unprotected Peptides through P-S Bond Formation.

Bioconjugate chemistry·2025
Same author

G protein peptidomimetics reveal allosteric effects and stepwise interactions in ghrelin receptor-G protein coupling.

Science signaling·2025
Same journal

Fluorinated Aminopiperidones as Non-Glutarimide Thalidomide Analogs: Stereodivergent Synthesis and Validation.

ChemMedChem·2026
Same journal

Pharmacology, Medicinal Chemistry, and Therapeutic Potential of Imidazoline Receptor Ligands.

ChemMedChem·2026
Same journal

Drug Repurposing Against Cestode Fatty Acid Binding Proteins Through Integrated Virtual Screening and In Vitro Validation.

ChemMedChem·2026
Same journal

Investigating the Inhibitory Properties of Diazo and Pyrazole-Carboxamide-Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII.

ChemMedChem·2026
Same journal

Quinoxaline-Based Monoamine Oxidase Inhibitors: Design Strategies, Synthesis, Structure-Activity Relationships, and Therapeutic Potential in Neurological Disorders: A Review From 1996 to 2026.

ChemMedChem·2026
Same journal

Immunomodulatory Potential of Quinoline Q3, a Selective Inhibitor of the Canonical NF-κB Pathway in Macrophages.

ChemMedChem·2026
See all related articles

Ghrelin, a stomach hormone, stimulates appetite and growth hormone release. Its receptor, GHS-R1a, is a target for potential new therapies influencing metabolism and internal medicine fields.

Area of Science:

  • Neuroendocrinology
  • Metabolic Research
  • Internal Medicine

Background:

  • Ghrelin is a 28-amino acid peptide hormone produced mainly in the stomach.
  • It plays a key role in stimulating growth hormone secretion and appetite, influencing food intake and body weight.
  • Its biological activities are mediated by the growth hormone secretagogue receptor type 1a (GHS-R1a).

Purpose of the Study:

  • To review the various types of GHS-R1a ligands.
  • To discuss recent advancements in the research of GHS-R1a ligands.
  • To highlight the clinical and therapeutic potential of these ligands.

Main Methods:

  • Literature review of described GHS-R1a ligands.
  • Analysis of recent progress in GHS-R1a ligand research.

Related Experiment Videos

Main Results:

  • Identification of diverse GHS-R1a ligands, including agonists, partial agonists, antagonists, and inverse agonists.
  • Summary of recent scientific progress in the development and understanding of these ligands.

Conclusions:

  • The discovery of ghrelin and GHS-R1a has significant implications for neuroendocrine and metabolic research.
  • GHS-R1a ligands show considerable clinical and therapeutic potential across various medical fields like gastroenterology, oncology, and cardiology.